Welcome to our dedicated page for Simulations Plus SEC filings (Ticker: SLP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Simulations Plus, Inc. (Nasdaq: SLP) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including annual and quarterly reports, proxy statements, and current reports on Form 8‑K. As a California corporation in the professional, scientific, and technical services sector, Simulations Plus files with the U.S. Securities and Exchange Commission under file number 001‑32046.
Annual reports on Form 10‑K and quarterly reports on Form 10‑Q give detailed information on the company’s software and services segments, revenue mix, cost structure, research and development spending, and risk factors related to its biosimulation, cheminformatics, and consulting activities. These filings also describe the integration of AI/ML, PBPK, QSP/QST, and related modeling approaches that underpin its model‑informed and AI‑accelerated drug development offerings.
Proxy statements (DEF 14A) include information on board elections, auditor ratification, and equity incentive plans. For example, the company’s definitive proxy statement details proposals such as increasing shares authorized under the 2021 Equity Incentive Plan, board and committee structures, corporate governance practices, and executive compensation frameworks.
Current reports on Form 8‑K disclose material events such as changes in the independent registered public accounting firm, preliminary financial results and guidance, executive employment agreements, and scheduling of earnings releases and conference calls. These documents help investors understand governance decisions, auditor transitions, and key operational updates.
On Stock Titan, these filings are paired with AI‑powered summaries that highlight important points from lengthy documents, helping readers quickly identify items such as segment performance discussions, non‑GAAP reconciliations, equity plan amendments, and auditor changes. Users can also review filings related to compensation and equity awards, as well as other disclosures that shape the regulatory and governance profile of Simulations Plus.
Simulations Plus, Inc. insiders Walter S. Woltosz and Virginia E. Woltosz reported an equity award of common stock. On January 30, 2026, 1,776 shares of Simulations Plus common stock were granted at a price of $0 as independent director compensation under the company’s 2021 Equity Incentive Plan.
Following this grant, the reporting persons disclosed beneficial ownership of 3,280,683 shares of Simulations Plus common stock held directly.
Simulations Plus director Sharlene Evans received a stock grant as part of her board compensation. On 01/30/2026, she acquired 1,776 shares of Simulations Plus common stock at a price of $0 per share, issued under the company’s 2021 Equity Incentive Plan.
After this grant, Evans beneficially owned 15,056 shares of Simulations Plus common stock in total, held directly.
Simulations Plus director Daniel L. Weiner received a stock grant as part of his board compensation. On January 30, 2026, he was awarded 1,776 shares of common stock at a price of $0 per share, reflecting stock granted under the company’s 2021 Equity Incentive Plan. Following this grant, he beneficially owned 14,430 shares of Simulations Plus common stock, held directly.
Simulations Plus, Inc. disclosed that director John Kenneth Paglia received a grant of 1,776 shares of Common Stock on January 30, 2026. The shares were granted as independent director compensation under the company’s 2021 Equity Incentive Plan at a reported price of $0 per share.
Following this stock award, Paglia now beneficially owns 12,472 shares of Simulations Plus common stock in direct ownership form.
The Vanguard Group filed a Schedule 13G showing a passive stake in Simulations Plus Inc. As of 12/31/2025, Vanguard reported beneficial ownership of 1,011,706 shares of Simulations Plus common stock, representing 5.02% of the class.
Vanguard reports no sole voting or dispositive power, with 121,295 shares subject to shared voting power and 1,011,706 shares subject to shared dispositive power. The filing states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Simulations Plus.
Simulations Plus, Inc. executive Jill Fiedler-Kelly exercised employee stock options and increased her direct shareholdings. On January 28, 2026, she exercised 8,950 fully vested employee stock options at an exercise price of $9.71 per share, receiving the same number of common shares.
Following this transaction, Fiedler-Kelly directly owned 77,817 shares of Simulations Plus common stock. The reported employee stock option position involved in this exercise was reduced to zero after the transaction, indicating the option grant was fully used.
Simulations Plus, Inc. reported first‑quarter results showing higher profitability and stronger cash generation despite a slight dip in revenue. Total revenue for the three months ended November 30, 2025 was $18.4 million, down 3% from $18.9 million a year earlier, as software revenue fell 17% to $8.9 million, partly offset by a 16% increase in services revenue to $9.5 million.
Cost of revenues declined 14%, lifting gross profit 7% to $10.9 million and expanding gross margin to 59% from 54%. Net income rose to $0.7 million (basic and diluted EPS $0.03) from $0.2 million ($0.01) despite a higher tax rate, helped by lower software amortization and reduced G&A. Operating cash flow improved to $4.2 million from a use of $1.3 million, supported by stronger working capital inflows and higher deferred revenue. The company increased R&D spending to 21% of revenue (capitalized plus expensed) to enhance its software platforms while maintaining a solid balance sheet with $30.2 million in cash and cash equivalents and $5.5 million in short‑term investments.
Simulations Plus, Inc. reported that it has released financial results for its first quarter ended November 30, 2025. On January 8, 2026, the company issued a press release with these results and held an investor conference call to discuss performance for the quarter.
The press release is furnished as Exhibit 99.1 and the PowerPoint presentation used on the call is furnished as Exhibit 99.2. These materials are being furnished, not filed, which limits their use for certain legal purposes. The company also includes standard cautionary language that its disclosures and exhibits contain forward-looking statements subject to significant risks and uncertainties that could cause actual results to differ materially.
Simulations Plus, Inc. is asking shareholders to vote at a virtual annual meeting on February 12, 2026. Shareholders of record on December 15, 2025, when 20,146,585 common shares were outstanding, can vote online, by phone, by mail, or during the webcast.
There are three key proposals. First, elect four directors: Dr. Daniel Weiner, Dr. Walter S. Woltosz, Dr. John K. Paglia, and Sharlene Evans. Second, ratify Rose, Snyder & Jacobs LLP as independent registered public accounting firm for the fiscal year ending August 31, 2026. The proxy explains prior changes between RSJ and Grant Thornton LLP and reports RSJ audit fees of $370,500 for 2025 and $479,500 for 2024.
Third, approve an amendment to the 2021 Equity Incentive Plan to increase shares reserved from 2,500,000 to 3,450,000. As of December 15, 2025, 2,568,762 shares were subject to outstanding awards and 410,131 shares remained available. The Board believes additional shares are needed to continue granting equity to employees, officers, directors, and service providers, and unanimously recommends voting FOR all three proposals.
Simulations Plus, Inc. entered into amended and restated employment agreements with its CEO, CFO, Chief Revenue Officer, and President of Service Solutions, and new agreements with its Co‑Chief Product & Technology Officer, COO, and Chief Scientific Officer, all effective December 2, 2025. The contracts set base salaries, performance‑based cash bonuses, and stock option targets under the company’s 2021 Equity Incentive Plan.
The CEO’s package includes a base salary of $547,700, a target cash bonus equal to 75% of salary, a target grant of 50,000 stock options, and potential additional discretionary cash and options. Other executives receive base salaries ranging from $283,100 to $359,100 with bonus targets of 25%–35% of salary and stock option targets of 15,000–20,000 options. If any covered executive is terminated without cause and signs a release, they are entitled to a one‑time payment equal to 12 months of base salary plus 12 months of COBRA health coverage paid by the company.